Swedbank AB Purchases 6,534 Shares of Humana Inc. $HUM

Swedbank AB raised its stake in Humana Inc. (NYSE:HUM) by 6.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 111,803 shares of the insurance provider’s stock after acquiring an additional 6,534 shares during the quarter. Swedbank AB’s holdings in Humana were worth $28,636,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. Montag A & Associates Inc. boosted its stake in Humana by 1,880.0% in the fourth quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares in the last quarter. CoreCap Advisors LLC boosted its stake in Humana by 54.4% in the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 37 shares in the last quarter. Rosenberg Matthew Hamilton boosted its stake in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares in the last quarter. Larson Financial Group LLC boosted its stake in Humana by 114.1% in the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock worth $40,000 after purchasing an additional 81 shares in the last quarter. Finally, Fulcrum Asset Management LLP acquired a new position in Humana in the third quarter worth $42,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have commented on HUM. Truist Financial boosted their price objective on Humana from $220.00 to $270.00 and gave the stock a “hold” rating in a research note on Thursday, April 30th. Royal Bank Of Canada upped their price target on Humana from $189.00 to $246.00 and gave the company a “sector perform” rating in a research note on Thursday, April 30th. Seaport Research Partners lowered Humana to a “neutral” rating in a research note on Wednesday. Oppenheimer raised Humana from an “outperform” rating to an “outperform” rating in a research note on Wednesday. Finally, Robert W. Baird cut their price target on Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Nine investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and four have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $263.35.

Humana Trading Down 0.1%

NYSE:HUM opened at $307.79 on Monday. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $315.66. The business’s 50-day moving average price is $218.13 and its two-hundred day moving average price is $227.27. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $36.95 billion, a price-to-earnings ratio of 32.92, a PEG ratio of 2.86 and a beta of 0.68.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to analyst estimates of $39.37 billion. During the same quarter in the prior year, the firm posted $11.58 earnings per share. The company’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts expect that Humana Inc. will post 9.01 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. The ex-dividend date is Friday, June 26th. Humana’s dividend payout ratio is 37.86%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.